Accreditation Statements

• DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 3.25 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Rheumatology Association of Iowa. DMU designates this live activity for 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Other healthcare providers: This activity is designated for 3.25 AMA PRA Category 1 Credit(s)™.

Educational Grants

Thank you to the following companies for their generous financial support of this continuing education activity.

• Coming soon.

Disclosures

The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

• Seth Brown, JD - Speaker
• Grace Fleming, CNP - Activity Director, Activity Coordinator, and Planning Committee Member
• Shivani Garg, MD, PhD, MS - Speaker
• Lindsay Orris, DO - Speaker

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated through peer review by individuals with no relevant financial relationships or through attestation to evidence-based guidelines for clinical recommendations.

• Daniella Schwartz, MD - Speaker
  • Consultant: Sobi
  • Grant or Research Support: Sobi, Eli Lilly
  • Speaker' Bureau: Sobi
  • The financial relationships have not ended; however, the Speaker's Bureau relationship is relevant to the content of the education activity.
  • The speaker intends to discuss the off-label use of a commercial product or device and agrees to inform learners. 
• Hanna Zembrzuska, MD, MME, FACP - Planning Committee Member
  • Consultant: Mustang Bio, Novartis, UCB
  • The financial relationships have not ended; however, they are not relevant to the educational activity.

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.